Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer.

Urology - 1 Aug 2003

Lin Cheng-Chieh, Wu Hsi-Chin, Tsai Fuu-Jen, Chen Huey-Yi, Chen Wen-Chi

Abstract excerpt

OBJECTIVES: To use the Bst U I polymorphism as a genetic marker in the search for the association between patients with prostate cancer and normal control subjects. The formation or progression of prostate cancer is presumed to be associated with a polymorphism of the vascular endothelial growth factor (VEGF) gene. The most frequently seen polymorphism is Bst U I (C to T) located at the -460th nucleotide upstream...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytosine

Share to Genetic Markers

Share to Polymorphism, Single Nucleotide

Share to Predictive Value of Tests

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 12893367
DOI: 10.1016/s0090-4295(03)00268-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer.PMID 12893367Read ↗

Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer.Semantic proximity Read ↗

No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.Semantic proximity Read ↗

[Vitamin D receptor gene Bsm I polymorphism and the susceptibility to prostate cancer in northern Chinese Han population].Semantic proximity Read ↗

Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancerSemantic proximity Read ↗

[Association of polymorphisms in testosterone 5-alpha-reductase II genotype and prognosis factors of prostate cancer].Semantic proximity Read ↗

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.Semantic proximity Read ↗

T allele for VEGF gene-460 polymorphism at the 5'-untranslated region: association with a higher susceptibility to endometriosis.Semantic proximity Read ↗

[V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer].Semantic proximity Read ↗

Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer.Semantic proximity Read ↗

Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.Semantic proximity Read ↗

Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.Semantic proximity Read ↗

Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.